TotalMarketCap

PharmaCyte Biotech

PMCBNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$4.028 M

$0.38 -1.52%

Close of 6 Nov 2026

As of 6 Nov 2026, PharmaCyte Biotech (PMCB) has a market capitalization of $4.03M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$0.00

#3616 by revenue

Earnings

-$19.4M

Loss-making

Shares outstanding

10,735,649

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #155Creative Medical TechnologyCELZ$4.63M
  2. #156Black TitanBTTC$4.33M
  3. #157PharmaCyte BiotechPMCB$4.03M
  4. #158Liminatus PharmaLIMN$3.53M
  5. #159Tessera Defense & Homeland SecurityHLSQ$3.22M

What if PharmaCyte Biotech were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,630,197

Per share 7,010,120× higher

Bitcoin $1.53T

$142,315.37

Per share 379,305× higher

Apple $5.02T

$467,208.08

Per share 1,245,224× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for PharmaCyte Biotech are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.